Trial Site Detail

 

Drug:
neoBOMB1
Trial:
[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-NeoB Lesion Uptake (NeoRay)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

University of Pittsburgh Cancer Institute

     
Pittsburgh , PA 15232
USA

 

Principal Investigator:
Dr. Ravi Patel
Contact:
Activation Status of this Site:
Active
Notes about this Site:
University of Pittsburgh Cancer Institute Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.